| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate |
1992-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0863586e1fbde586b3ed47137931c704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf6f6a5b71e2b17e5ba7fd573e7908a |
| publicationDate |
1993-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H05331169-A |
| titleOfInvention |
Benzonaphthyridine derivative |
| abstract |
(57) [Summary] [Purpose] Providing a glutamate receptor antagonist with excellent brain translocation and few side effects [Constitution] For example, the formula [Chemical formula 1] Benznaphthyridine derivative represented by |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9514670-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-682736-B2 |
| priorityDate |
1992-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |